Human herpesvirus 8-related Castleman disease in the absence of HIV infection

Clinical Infectious Diseases

Volumn 56, Issue 6, 2013, Pages 833-842

  Dossier, A ^a,b   Meignin, V ^a   Fieschi, C ^a   Boutboul, D ^a   Oksenhendler, E ^a   Galicier, L ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Castleman disease; Giant lymph node hyperplasia; HHV 8; HIV; immunocompetent

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; RITUXIMAB; VINBLASTINE; VINCRISTINE; VIRUS DNA;

ADULT; AGED; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EDEMA; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KAPOSI SARCOMA; KIDNEY DISEASE; LABORATORY TEST; LUNG DISEASE; LYMPHADENOPATHY; LYMPHOMA; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; PLASMABLASTIC LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SERODIAGNOSIS; SPLENOMEGALY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; DNA, VIRAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84874775510     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis1009     Document Type: Article

References (40)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9:822-30.
2. Flendrig JA. Benign giant lymphoma: clinicopathologic correlation study. In: Clark RL, Cumley RW, eds. The year book of cancer. Chicago: Year Book Medical, 1970: 296-9.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasmacell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29:670-83.
4. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69:86-90.
5. Rywlin AM, Rosen L, Cabello B. Coexistence of Castleman's disease and Kaposi's sarcoma. Report of a case and a speculation. Am J Dermatopathol 1983; 5:277-81.
6. Lachant NA, Sun NC, Leong LA, Oseas RS, Prince HE. Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 1985; 83: 27-33.
7. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985; 3:1202-16.
8. Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 1985; 56:2446-51.
9. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-80.
10. Oksenhendler E, Duarte M, Soulier J, et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996; 10:61-7.
11. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 2000; 96:2069-73.
12. Gérard L, Bérezné A, Galicier L, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol 2007; 25:3350-6.
13. Powles T, Stebbing J, Bazeos A, et al. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Ann Oncol 2009; 20:775-9.
14. Stebbing J, Adams C, Sanitt A, et al. Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease. Blood 2011; 118:271-5.
15. Bower M, Newsom-Davis T, Naresh K, et al. Clinical features and outcome in HIV-associated multicentric Castleman's disease. J Clin Oncol 2011; 29:2481-6.
16. Sobngwi E, Choukem SP, Agbalika F, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans. JAMA 2008; 299:2770-6.
17. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 2012; 63:233-46.
18. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
19. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDSrelated body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
20. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8- positive plasmablastic lymphoma. Blood 2000; 95:1406-12.
21. Parravicini C, Chandran B, Corbellino M, et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirusinfected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 2000; 156: 743-49.
22. Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001; 97:2130-6.
23. Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesviruslinked disorders. Blood 2001; 97:2173-6.
24. Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, et al. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood 2012; 119:5173-81.
25. Wong SW, Bergquam EP, Swanson RM, et al. Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus. J Exp Med 1999; 190:827-40.
26. Codish S, Abu-Shakra M, Ariad S, et al. Manifestations of three HHV- 8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma. Am J Hematol 2000; 65:310-4.
27. Caussinus E, Meggetto F, Delsol G, Brousset P. Simultaneous occurrence of Epstein-Barr virus associated Hodgkin's disease and HHV-8 related multicentric Castleman's disease: a fortuitous event? J Clin Pathol 2001; 54:790-1.
28. Li C-F, Ye H, Liu H, Du M-Q, Chuang S-S. Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol 2006; 30:123-7.
29. Nicoli P, Familiari U, Bosa M, et al. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol 2009; 90:392-6.
30. Law AB, Ryan G, Lade S, Prince HM. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient. Int J Hematol 2010; 91:347-8; author reply 349.
31. Marietta M, Pozzi S, Luppi M, et al. Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report. Eur J Haematol 2003; 70:181-2.
32. Bollen J, Polstra A, Van Der Kuyl A, et al. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report. BMC Blood Disord 2003; 3:3.
33. Cervera Grau JM, Galiana Esquerdo G, Llorca Ferrándiz C, Briceño García H, Díaz Castellano M, Férriz Moreno P. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20. Clin Transl Oncol 2006; 8:540-1.
34. Kim B, Jeon YK, Kim CW. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric Castleman disease and Kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case. J Korean Med Sci 2009; 24:970-4.
35. Fragasso A, Mannarella C, Ciancio A, Calvario A, Scarasciulli ML. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIVnegative, HHV-8 positive patient with multicentric Castleman disease. Leuk Lymphoma 2008; 49:2224-6.
36. Jacobs SA, Vidnovic N, Patel H, et al. Durable remission of HIVnegative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate. Clin. Rheumatol 2007; 26:1148-50.
37. Pastor MA, Vasco B, Mosquera JM, Debén G, Bautista P, Requena L. Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with rituximab and CHOP. Actas Dermosifiliogr 2006; 97:385-90.
38. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99:2331-6.
39. Gérard L, Michot J-M, Burcheri S, et al. Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood 2012; 119:2228-33.
40. Papo T, Soubrier M, Marcelin AG, et al. Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome. Br J Haematol 1999; 104:932-3.